by The global Hyperthermia Cancer Treatment Market is estimated to be valued at US$ 187.05 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Hyperthermia Cancer Treatment utilizes targeted heating to kill or weaken cancer cells through heat exposure. Cancer cells are more vulnerable to heat than normal cells. Hyperthermia aims to heat the targeted area to temperatures up to 106°F in order to damage and destroy cancer cells or make them more sensitive to radiation therapy and chemotherapy.
Market key trends:
One of the key trends in the hyperthermia cancer treatment market is the growing preference for minimally invasive procedures. Hyperthermia treatment devices are being developed that deliver localized heating through non-invasive means such as electromagnetic waves or ultrasound. For example, magnetic inductive hyperthermia uses magnetic induction to induce heat within cancer tissue from outside the body. This avoids complications associated with invasive surgery and allows for repeat treatments. Rising demand for painless and effective treatment options is expected to drive increased adoption of minimally invasive hyperthermia technologies over the forecast period. The hyperthermia cancer treatment market is experiencing increased adoption owing to increasing prevalence of cancer worldwide. Hyperthermia is being used increasingly as an adjuvant therapy with chemotherapy or radiation therapy for treating various types of cancer like rectal cancer, breast cancer, brain cancer, bladder cancer etc. Development of innovative technologies that help deliver hyperthermia more effectively and accurately are also fueling the market growth.
SWOT Analysis
Strengths: Non-invasive nature, ability to enhance efficacy of chemotherapy and radiation therapy.
Weaknesses: Requires specialized equipment and trained medical professionals, risk of side effects like burns.
Opportunities: Increasing R&D for combination therapies, untapped emerging markets.
Threats: High costs associated, availability of alternative treatments.
Key Takeaways
The Global Hyperthermia Cancer Treatment Market Size is expected to witness high growth, exhibiting CAGR of 6.1% over the forecast period, due to increasing prevalence of cancer worldwide. North America is expected to dominate the market during the forecast period due to growing adoption of advanced technologies and presence of major players.
The global Hyperthermia Cancer Treatment market size for 2023 is US$ 187.05 Bn. Regional analysis: Asia Pacific market is anticipated to exhibit fastest growth rate during the forecast period owing to increasing healthcare investments, rising awareness about cancer treatment options in the region.
Key players operating in the Hyperthermia Cancer Treatment are MagForce AG, Andromedic, Xianke Medical Equipment, OncoTherm, Celsius42+, Oncotherm, Pyrexar Medical, Yamamoto Vinita, Nanoprobes, Alba Hyperthermia System, Nova Company, Perseon, Omron, Sunny Medical Equipment, OrienTech, BSD Medical, Sensius, Celsius42, Nanjing Greathope, Shanghai Huayuan
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
